Pithecellobium clypearia 和酸通过增强肠道上皮质化和屏障功能来保护大肠炎
Hailin Zhong1, Yijing Cai1, Jingyan Jin1
1NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Pithecellobium clypearia 提取物及其成分酸通过增强肠道粘液屏障和调节肠道微生物群来预防性结肠炎 (UC). 这项研究揭示了一种针对炎症性肠病的新型治疗方法.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 微生物组研究 微生物组研究
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,导致患者显著的死亡率.
- (P. clypearia) 是一种具有潜在抗炎功能的传统草药.
- 在UC中P. clypearia的治疗机制尚不清楚.
研究的目的:
- 为了研究P. clypearia提取物对小鼠中硫酸 (DSS) 诱导的大肠炎的保护作用.
- 阐明P. clypearia在UC中的作用的潜在分子和微生物机制.
- 评估酸在UC治疗中的特殊作用,酸是P. clypearia的关键组成部分.
主要方法:
- 建立了一个DSS诱导的大肠炎小鼠模型来评估P. clypearia提取物的疗效.
- 进行了综合的转录基因,代谢基因和16S rRNA测序,以进行全面的分析.
- 在体内和体外验证了酸的作用.
主要成果:
- 治疗P. clypearia增强了粘液屏障的完整性,通过调高与fucosylation相关的基因 (Fut2,Fut9) 和上皮质糖化.
- 代谢分析显示有机碳酸盐的增加,微生物群分析显示阿克尔曼西亚的丰富.
- 单独的酸复制了P. clypearia的保护作用,证明了它在上皮质修复和微生物调节中的作用.
结论:
- P. clypearia对实验性结肠炎表现出显著的保护作用.
- 酸是一个关键的活性成分,负责UC中P. clypearia的治疗效果.
- 这项研究强调了性结肠炎的潜在自然治疗策略,包括表皮屏障恢复和微生物组调节.
更多相关视频
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
06:31Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
相关概念视频
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Renewal of Intestinal Stem Cells
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
